MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
1262.89%
Quick Ratio
1262.89%
Cash Ratio
1156.24%
Debt to Asset Ratio
8.18%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Operating lease right-of-use ass...
Other assets
Short-term investments
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
73,849
62,436
47,051
39,285
Short-term investments
21
28,764
62,976
87,065
Prepaid expenses and other current assets
6,791
2,380
1,859
2,857
Total current assets
80,661
93,580
111,886
129,207
Operating lease right-of-use asset
626
269
355
439
Other assets
173
4,741
4,940
3,583
Total assets
81,460
98,590
117,181
133,229
Accounts payable
2,086
4,493
2,072
4,444
Accrued liabilities
3,900
6,775
8,035
5,863
Operating lease liability, current portion
401
336
441
429
Total current liabilities
6,387
11,604
10,548
10,736
Operating lease liability, net of current portion
276
-
0
116
Other long-term liabilities
-
-
0
0
Total liabilities
6,663
11,604
10,548
10,852
Additional paid-in capital
226,690
224,478
222,470
220,615
Accumulated other comprehensive income
0
14
81
82
Accumulated deficit
-151,893
-137,506
-115,918
-98,320
Total stockholders' equity
74,797
86,986
106,633
122,377
Total liabilities and stockholders' equity
81,460
98,590
117,181
133,229
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$73,849K
(184.06%↑ Y/Y)
Prepaid expenses and
other current assets
$6,791K
(130.36%↑ Y/Y)
Short-term investments
$21K
(-99.98%↓ Y/Y)
Total current assets
$80,661K
(-44.28%↓ Y/Y)
Operating lease
right-of-use asset
$626K
(19.92%↑ Y/Y)
Other assets
$173K
(-92.08%↓ Y/Y)
Total assets
$81,460K
(-44.76%↓ Y/Y)
Total liabilities and
stockholders' equity
$81,460K
(-44.76%↓ Y/Y)
Total stockholders'
equity
$74,797K
(-45.37%↓ Y/Y)
Total liabilities
$6,663K
(-36.84%↓ Y/Y)
Accumulated deficit
-$151,893K
(-85.23%↓ Y/Y)
Additional paid-in capital
$226,690K
(3.54%↑ Y/Y)
Total current
liabilities
$6,387K
(-38.05%↓ Y/Y)
Operating lease
liability, net of current...
$276K
(21.05%↑ Y/Y)
Accrued liabilities
$3,900K
(-19.37%↓ Y/Y)
Accounts payable
$2,086K
(-58.74%↓ Y/Y)
Operating lease
liability, current portion
$401K
(-3.84%↓ Y/Y)
Buy us a coffee
Aardvark Therapeutics, Inc. (AARD)
Aardvark Therapeutics, Inc. (AARD)